Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease    source : Www.igmbio.com    save search
IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication of Preclinical Data in Nature Demonstrating Engineered IgM Antibody Antiviral Activity for the Treatment and Prevention of COVID-19
Published: 2021-06-03 (Crawled : 14:00) - igmbio.com
IGMS | $7.24 -2.29% 47K twitter stocktwits trandingview |
Health Technology
 | | O: 1.77% H: 11.4% C: 6.85%
covid disease treatment infectious disease expansion antiviral antibody preclinical pre-clinical
Gainers vs Losers
79% 21%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance
EGOX | $0.0606 68.33% 250M twitter stocktwits trandingview |

NVFY | $3.45 63.51% 20M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.98 36.55% 27M twitter stocktwits trandingview |
Commercial Services
CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a
INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals
PAPL | $2.07 26.22% 550K twitter stocktwits trandingview |

RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a
AULT | $0.304 25.57% 47M twitter stocktwits trandingview |
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.